Evidence map›Paper›PMID 31614915›Full record

ArticlePolymers2019

Targeted Release of Probiotics from Enteric Microparticulated Formulations.

Cristina Yus, Ruben Gracia, Ane Larrea, Vanesa Andreu, Silvia Irusta, Victor Sebastian, Gracia Mendoza, Manuel Arruebo

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Development, Optimization and Characterization of EudraguardPharmaceuticals (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cristina YusDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. cyargon@gmail.com.
Ruben GraciaDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. r.gracia1992@gmail.com.
Ane LarreaDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. ane.larreaibanez@gmail.com.
Vanesa AndreuDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. vandreu@unizar.es.ORCID 0000-0002-6275-1104
Silvia IrustaDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. sirusta@unizar.es.ORCID 0000-0002-2966-9088
Victor SebastianDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. victorse@unizar.es.ORCID 0000-0002-6873-5244
Gracia MendozaDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. gmmenc@unizar.es.
Manuel ArrueboDepartment of Chemical Engineering. Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain. arruebom@unizar.es.ORCID 0000-0003-3165-0156
Universidad de Zaragoza · ES

Funding

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina CIBER-BBNEuropean Research Council ERC-2013-CoG-614715, NANOHEDONISM
6 · The paper itself

Abstract

The development of advanced probiotic delivery systems, which preserve bacteria from degradation of the gastrointestinal tract and achieve a targeted release mediated by pH-independent swelling, is of great interest to improve the efficient delivery of probiotic bacteria to the target tissue. Gram-positive and Gram-negative bacteria models (

Indexed as

enteric coatingEudragitEudraguardpolymethacrylateprobioticstarget delivery

Identifiers

PMID31614915
PMCPMC6835770
OpenAlexW2980164103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.